Integrated approaches to fighting colorectal cancer

Organized as part of the CHARM-EU European University, the international conference "Integrated approaches to fight colorectal cancer: all together to break down barriers" takes place on September 25, 2024.

The event marks the start of an experimental international teaching module for students from the University of Montpellier and the University of Utrecht, both members of the CHARM-EU alliance of European universities.

The conference will bring together clinicians, researchers and patient associations (Digestive cancers Europe, Mon réseau cancer colorectal...) to share their expertise with international students from different disciplines. A unique opportunity for all those involved in the fight against colorectal cancer to meet, exchange ideas and innovate together.

Following the conference, teams of students will work to propose research projects linked to pathology, with the support of the international network of researchers interested in this theme. This new interdisciplinary and international module "Tackling challenges through international linked research hub" leverages the excellence of international research networks to tackle global challenges in line with the three pillars of the I-Site Nourrir-Soigner-Protéger label of excellence. Fully integrated into the various Masters courses offered by the Universities of Montpellier and Utrecht, it applies the innovative pedagogical principles of the CHARM-EU European University through an approach focused on solving real-life challenges, while preparing students to design a research project.

This event has been organized in conjunction with the SIRIC Montpellier Cancer, a site of excellence in oncology accredited by the French National Cancer Institute (INCa), whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several establishments are involved, in particular the Institut du Cancer de Montpellier, the Institut de Research en Cancérologie de Montpellier, and the Institut des Biomolécules Max Mousseron.